News Releases
Ruben Mesa, M.D., FACP, named executive director of the Mays Cancer Center
September 28, 2020
SAN ANTONIO (Sept. 28, 2020) — Ruben Mesa, MD, FACP, has been named executive director of the Mays Cancer Center. His appointment includes academic and research programming, as well as leading the cancer center’s patient care and clinical programs of the UT Health San Antonio MD Anderson affiliation. Dr. Mesa’s appointment broadens the scope of […]
160 genes linked to brain shrinkage in study of 45,000 adults
September 25, 2020
Comparison of genes and MRI results shows associations A new study implicates 160 genes in brain shrinkage seen on MRIs of 45,000 healthy adults. The shrinkage is in the cortex, the dimply outer layer of the brain that gives rise to thinking, awareness and action, and largely consists of gray matter. The study, published Sept. […]
Study: Childhood chemo alters heart’s caretaker cells
September 25, 2020
Clues sought for why 1 in 5 pediatric cancer survivors develop heart failure. Cancer chemotherapy changes the function of cells that repair heart injury, researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) discovered. Twenty percent of children treated with drugs called anthracyclines go on to suffer heart […]
Mays Cancer Center selected for ASCO quality improvement program
September 24, 2020
SAN ANTONIO — The Mays Cancer Center, home to UT Health San Antonio MD Anderson, is one of 10 institutions selected nationwide for the American Society of Clinical Oncology’s (ASCO) Quality Oncology Practice Initiative® and Quality Training Program Improvement Program. The three-year program is awarded to institutions that provide care to underserved communities. Adolfo Enrique […]
175 con prediabetes se necesitan para estudio con medicamentos
September 22, 2020
Se está invitando a 175 residentes del área a participar en un estudio de investigación clínica ofrecido por UT Health San Antonio y University Health System. El estudio, que se está llevando a cabo en el Instituto de la Diabetes de Texas (TDI), está comparando cuatro medicinas para ver cuál previene mejor la conversión a […]
175 with prediabetes needed for medications study
September 22, 2020
175 area residents with a diagnosis of prediabetes are encouraged to enroll in a clinical trial offered by UT Health San Antonio and University Health System. The study, conducted at the Texas Diabetes Institute (TDI), is comparing four medications to see which will best prevent conversion to Type 2 diabetes. “People with prediabetes are at […]